Immunotherapy for Breast Cancer: Who Qualifies and How It’s Making a Difference

29/05/2025 13 min
Immunotherapy for Breast Cancer: Who Qualifies and How It’s Making a Difference

Listen "Immunotherapy for Breast Cancer: Who Qualifies and How It’s Making a Difference"

Episode Synopsis

In this episode, we explore how immunotherapy is changing breast cancer treatment, especially for patients with hard-to-treat forms like metastatic triple-negative breast cancer.You’ll learn:What immunotherapy is and how it helps the immune system fight cancerThe role of immune checkpoint inhibitors in treating breast cancerWhat does PD-L1 expression and MSI-H status mean for your treatment optionsHow immunotherapy works at different stages of breast cancerWhy it’s most effective for metastatic and PD-L1-positive tumorsWhat side effects to expect and how doctors manage themIf you or a loved one is facing breast cancer, this episode breaks down who can benefit from immunotherapy—and how this treatment is offering new hope when other options fall short.Blog Link: Immunotherapy for Breast Cancer: Who Can Benefit?Send us a textThank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education. Author: Dr. CHRISTINA NG VAN TZE 📍 Visit us at oncolifecentre.com 📞 Call: +603-2242-2620 📧 Book a consultation or ask a question — we're here to support your journey.

More episodes of the podcast The Onco Life Podcast